A Study Evaluating the Use of 31P MRS to Assess Brain NAD+ Levels as Compared to Nicotinamide Riboside Supplementation in Healthy Current and Former Collegiate Athletes

Overview

Información sobre este estudio

The purpose of this study is to determine if nicotinamide riboside (750 mg/day for 12 weeks) can affect the levels of NAD+ in the brain as measured by 31P MRS.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Current and former adult collegiate male and female athletes.
  • Aged 18 years and older.
  • Participants in football, rugby, soccer, hockey, lacrosse, and/or volleyball. 
    • Note:  “Former collegiate athletes” is defined as having competed in the applicable sports within the previous two years.
  • Body mass index (estimated based on height and weight) from 20 to 37.
  • Agree to maintain current level of physical activity throughout the study
  • Willing and able to provide written informed consent.
  • Willing and able to ingest the test substance.
  • Willing and able to comply with study instructions.
  • Not pregnant or breast feeding

Exclusion Criteria:

  • Presence of prolonged (more than 5 minutes) loss of consciousness.
  • Normal contraindications to MRI procedures, including but not limited to implanted medical (metal, magnetic, or electronic) devices or having metal objects or pacemakers.
  • History of epilepsy.
  • History of more than 3 concussions.
  • History of headache preceding concussions.
  • History of complex spine and/or skull traumas.
  • History of depression preceding concussions.
  • History of intracranial bleeding or strokes.
  • History of post-traumatic seizures.
  • History of developmental delay.
  • History of ADHD.

 

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Brent Bauer, M.D.

Cerrado para la inscripción

Contact information:

Jennifer Soderlind

(507) 284-4799

Soderlind.Jennifer@mayo.edu

Minneapolis, Minn.

Investigador principal de Mayo Clinic

Brent Bauer, M.D.

Cerrado para la inscripción

Contact information:

Stephanie Lindeen R.N.

(507)284-4799

athletesstudy@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20201532

Mayo Clinic Footer